Profile | GDS5420 / 235096_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 1281.76 | 83 |
GSM1296119 | B_lesional_pre-dose | 972.7 | 79 |
GSM1296076 | C_lesional_pre-dose | 962.1 | 79 |
GSM1296092 | D_lesional_pre-dose | 765.2 | 75 |
GSM1296103 | E_lesional_pre-dose | 1272 | 83 |
GSM1296078 | F_lesional_pre-dose | 910.74 | 78 |
GSM1296107 | G_lesional_pre-dose | 799.98 | 76 |
GSM1296109 | H_lesional_pre-dose | 971.94 | 79 |
GSM1296080 | I_lesional_pre-dose | 528 | 69 |
GSM1296090 | J_lesional_pre-dose | 634.35 | 72 |
GSM1296074 | K_lesional_pre-dose | 885.08 | 77 |
GSM1296111 | L_lesional_pre-dose | 931.95 | 78 |
GSM1296099 | M_lesional_pre-dose | 1412.07 | 85 |
GSM1296086 | O_lesional_pre-dose | 814.12 | 76 |
GSM1296117 | P_lesional_pre-dose | 863.88 | 77 |
GSM1296113 | Q_lesional_pre-dose | 934.08 | 78 |
GSM1296096 | R_lesional_pre-dose | 1165.59 | 81 |
GSM1296105 | S_lesional_pre-dose | 746.23 | 74 |
GSM1296098 | T_lesional_pre-dose | 807.47 | 76 |
GSM1296101 | U_lesional_pre-dose | 812.19 | 76 |
GSM1296121 | V_lesional_pre-dose | 919.72 | 78 |
GSM1296088 | W_lesional_pre-dose | 776.53 | 75 |
GSM1296082 | X_lesional_pre-dose | 832.45 | 76 |
GSM1296115 | Y_lesional_pre-dose | 967.44 | 79 |
GSM1296084 | Z_lesional_pre-dose | 524.16 | 68 |
GSM1296072 | B_lesional_day8 | 714.36 | 74 |
GSM1296069 | L_lesional_day8 | 487.46 | 67 |
GSM1296071 | P_lesional_day8 | 551.89 | 69 |
GSM1296070 | Y_lesional_day8 | 582.55 | 70 |
GSM1296073 | V_lesional_day8 | 959.24 | 79 |
GSM1296034 | A_lesional_day15 | 523.13 | 68 |
GSM1296041 | G_lesional_day15 | 840.29 | 76 |
GSM1296035 | R_lesional_day15 | 1250.46 | 82 |
GSM1296038 | U_lesional_day15 | 792.94 | 75 |
GSM1296047 | B_lesional_day15 | 618.95 | 71 |
GSM1296039 | E_lesional_day15 | 1124.83 | 81 |
GSM1296042 | H_lesional_day15 | 634.47 | 72 |
GSM1296043 | L_lesional_day15 | 464.33 | 66 |
GSM1296037 | M_lesional_day15 | 463.52 | 66 |
GSM1296046 | P_lesional_day15 | 601.26 | 70 |
GSM1296044 | Q_lesional_day15 | 592.99 | 70 |
GSM1296045 | Y_lesional_day15 | 506.02 | 68 |
GSM1296025 | C_lesional_day15 | 392.06 | 64 |
GSM1296033 | D_lesional_day15 | 412.9 | 64 |
GSM1296027 | I_lesional_day15 | 219.19 | 55 |
GSM1296032 | J_lesional_day15 | 232.16 | 55 |
GSM1296024 | K_lesional_day15 | 337.53 | 61 |
GSM1296031 | W_lesional_day15 | 327.58 | 60 |
GSM1296028 | X_lesional_day15 | 261.21 | 57 |
GSM1296029 | Z_lesional_day15 | 294.44 | 59 |
GSM1296026 | F_lesional_day15 | 506.12 | 68 |
GSM1296030 | O_lesional_day15 | 504.1 | 68 |
GSM1296040 | S_lesional_day15 | 967.19 | 79 |
GSM1296036 | T_lesional_day15 | 681.17 | 72 |
GSM1296048 | V_lesional_day15 | 914.01 | 78 |
GSM1296059 | A_lesional_day43 | 1386.75 | 84 |
GSM1296066 | G_lesional_day43 | 797.35 | 76 |
GSM1296060 | R_lesional_day43 | 1009.26 | 79 |
GSM1296063 | U_lesional_day43 | 934.91 | 78 |
GSM1296064 | E_lesional_day43 | 1313.4 | 83 |
GSM1296067 | H_lesional_day43 | 645.64 | 72 |
GSM1296062 | M_lesional_day43 | 920.22 | 78 |
GSM1296068 | Q_lesional_day43 | 554.96 | 69 |
GSM1296050 | C_lesional_day43 | 314.39 | 60 |
GSM1296057 | D_lesional_day43 | 963.51 | 78 |
GSM1296052 | I_lesional_day43 | 161.55 | 50 |
GSM1296054 | J_lesional_day43 | 262.73 | 56 |
GSM1296049 | K_lesional_day43 | 354.96 | 62 |
GSM1296055 | W_lesional_day43 | 595.42 | 70 |
GSM1296053 | X_lesional_day43 | 230.31 | 54 |
GSM1296058 | Z_lesional_day43 | 821.75 | 76 |
GSM1296051 | F_lesional_day43 | 792.24 | 75 |
GSM1296056 | O_lesional_day43 | 1432.05 | 84 |
GSM1296065 | S_lesional_day43 | 933.09 | 78 |
GSM1296061 | T_lesional_day43 | 504.71 | 67 |
GSM1296095 | A_non-lesional_pre-dose | 1330.01 | 83 |
GSM1296120 | B_non-lesional_pre-dose | 544.08 | 69 |
GSM1296077 | C_non-lesional_pre-dose | 322.04 | 61 |
GSM1296093 | D_non-lesional_pre-dose | 252.91 | 55 |
GSM1296104 | E_non-lesional_pre-dose | 674.41 | 73 |
GSM1296079 | F_non-lesional_pre-dose | 377.42 | 63 |
GSM1296108 | G_non-lesional_pre-dose | 446.38 | 66 |
GSM1296110 | H_non-lesional_pre-dose | 628.77 | 71 |
GSM1296081 | I_non-lesional_pre-dose | 155.89 | 50 |
GSM1296091 | J_non-lesional_pre-dose | 338.86 | 61 |
GSM1296075 | K_non-lesional_pre-dose | 608.18 | 71 |
GSM1296112 | L_non-lesional_pre-dose | 350.62 | 60 |
GSM1296100 | M_non-lesional_pre-dose | 506.47 | 67 |
GSM1296087 | O_non-lesional_pre-dose | 172.58 | 52 |
GSM1296118 | P_non-lesional_pre-dose | 392.25 | 63 |
GSM1296114 | Q_non-lesional_pre-dose | 502.6 | 67 |
GSM1296097 | R_non-lesional_pre-dose | 652.07 | 72 |
GSM1296106 | S_non-lesional_pre-dose | 659.09 | 72 |
GSM1296102 | U_non-lesional_pre-dose | 433.3 | 64 |
GSM1296122 | V_non-lesional_pre-dose | 383.12 | 63 |
GSM1296089 | W_non-lesional_pre-dose | 294.61 | 58 |
GSM1296083 | X_non-lesional_pre-dose | 254.91 | 56 |
GSM1296116 | Y_non-lesional_pre-dose | 417.44 | 64 |
GSM1296085 | Z_non-lesional_pre-dose | 145.15 | 47 |